Skip to content

Author

A. Ambrosy

7 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Design of Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT-Echo-AI).

BACKGROUND Steatotic liver disease (SLD) is highly prevalent among individuals with cardiovascular disease, but often remains undiagnosed until advanced sequelae such as fibrotic liver disease and hepatocellular carcinoma develop. ​​Transthoracic echocardiography routinely captures incidental subcostal views of the liv...

Sahir Eusuff, Jay Kim, Zara Fatima et al. · 0 citations
Oct 2026

Sex Differences in the Prevalence, Medical Therapy, and Outcomes in Heart Failure With Improved Ejection Fraction.

BACKGROUND Heart failure with improved ejection fraction (HFimpEF) is a rapidly growing clinical entity. There is little understanding of how sex relates to the epidemiology, predictors, and trajectory of HFimpEF. OBJECTIVES The authors aimed to describe sex-based differences in the epidemiology, guideline-directed m...

Yi-Lin Liang, Lochan M. Shah, R. Parikh et al. · 1 citation
Review Open access Sep 2026

Practical Implementation of Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists in the Management of Heart Failure

Mineralocorticoid receptor antagonists (MRAs) are a well-established treatment option for the management of heart failure (HF) with reduced ejection fraction. However, high-quality evidence for the effect of MRAs in the treatment of heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) has bee...

E. Michos, A. Ambrosy, G. Fonarow · 0 citations
Review Sep 2026

From task-specific AI to cardiovascular foundation models: a new era of multimodal interpretation.

Artificial intelligence (AI) is reshaping cardiovascular medicine, evolving from task-specific supervised models towards multitask and foundation models capable of broader, more scalable interpretation. Early AI systems achieved high performance in electrocardiographic interpretation, echocardiographic measurement and...

Hirotaka Ieki, Paul P. Cheng, A. Ambrosy et al. · 0 citations
Oct 2026

Comprehensive Aortic Stenosis Characterization Using Multiview Deep Learning.

BACKGROUND Accurate assessment of aortic stenosis (AS) requires integration of both structural and functional information characterized by visual traits as well as quantitation of gradients. Existing artificial intelligence models use solely either structural or functional information. OBJECTIVES The authors aimed to...

Hirotaka Ieki, Y. Sahashi, M. Vukadinovic et al. · 2 citations
Open access Sep 2026

Get With The Guidelines-Heart Failure Hospital Participation and Its Association With Guideline-Directed Medical Therapy and Outcomes.

Hospital participation in GWTG-HF was associated with modest but significant improvements in postdischarge GDMT intensity, supporting the value of quality improvement initiatives to address persistent treatment gaps in heart failure with reduced ejection fraction.

Aradhana Verma, Greg C. Fonarow, Paul A. Heidenreich et al. · 0 citations
Aug 2026

Initial Diuretic Strategy During Hospitalization for Heart Failure and Associated Outcomes: Insights from the TREAT-AHF Registry.

BACKGROUND Real-world data regarding diuretic strategies and associated outcomes in patients hospitalized for heart failure (HF) in community health systems are limited. OBJECTIVES Evaluate associations between initial diuretic therapy, markers of decongestion, and clinical outcomes in patients hospitalized for HF....

A. Varshney, A. Ambrosy, Adam Furst et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.